Abstract
Pregnancy-associated breast cancer is challenging to treat. Treatment with chemotherapeutic agents such as anthracyclines poses a risk of cardiotoxicity, despite being considered safe after the second trimester of pregnancy. Management requires multidisciplinary comanagement with cardio-obstetrics, cardiology-oncology, maternal-fetal medicine, and oncology.
Original language | English (US) |
---|---|
Article number | 102141 |
Journal | JACC: Case Reports |
Volume | 28 |
DOIs | |
State | Published - Dec 20 2023 |
Keywords
- cancer
- cardiomyopathy
- pregnancy
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine